NeuroSense Therapeutics Ltd.
NRSNW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001875091
No open-market purchases or sales by NeuroSense Therapeutics Ltd. insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $10.4K in total; no superinvestor holds it.
Other share classesNRSN
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, 0 vs. previous quarter
- 3
- 13F valueReported value at the end of Q2 2026
- $10.4K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding NRSNW, Q2 2026
No superinvestor reported holding NRSNW at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by NeuroSense Therapeutics Ltd. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 (view filing) | Jun 16 | 1 day | Ben-Noon AlonChief Executive Officer | PPurchase | +250.0K | $0.80 | +$200.0K | +5.8%4.53M after | |
| Jun 17, 2026 (view filing) | Jun 16 | 1 day | Eisenberg OrChief Financial Officer | PPurchase | +250.0K | $0.80 | +$200.0K | +19.9%1.50M after |
Top 10 13F holders, Q2 2026
The largest institutional positions in NeuroSense Therapeutics Ltd. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Empery Asset Management, LP | 100,402 | $6.33K | 0.01% | 00.0% | Unchanged |
| Clear Street Group Inc. | 63,085 | $3.97K | 0.00% | −300−0.5% | Reduced |
| UBS Group AG | 1,163 | $73 | 0.00% | 00.0% | Unchanged |